Fetal therapy is treatment performed during pregnancy for a selected fetal or placental condition. The aim is not to “correct” every abnormal ultrasound finding. It is to identify the relatively small group of situations in which intervening before birth may reduce serious harm, improve the condition at delivery, or create time for further development.
The field includes ultrasound-guided needle procedures, fetal blood transfusion, drainage or shunt placement, and fetoscopic procedures. Some interventions treat a mechanism directly, such as severe fetal anaemia or abnormal placental blood-vessel connections in twin-to-twin transfusion syndrome. Others decompress a fluid-filled space or relieve an obstruction in carefully selected cases.
Assessment comes before treatment
The same ultrasound label can represent different diseases and prognoses. Before a procedure is considered, the team usually needs to confirm pregnancy dating, fetal anatomy, placental location, chorionicity in twins, blood flow, fluid volumes, maternal condition, genetic or infection information, and how the findings are changing over time.
The assessment asks four separate questions:
- Is the diagnosis sufficiently certain?
- Is the condition severe or progressive enough to justify intervention?
- Is there evidence that prenatal treatment could offer a meaningful benefit?
- Are the maternal, fetal, technical, and logistical risks acceptable in this individual pregnancy?
Candidacy is not automatic
A referral for fetal therapy does not mean that a procedure will be recommended. Gestational age may be outside the evidence-supported window. Additional abnormalities may change the likely benefit. Maternal health, placental access, cervical findings, membrane status, fetal position, or technical factors may alter feasibility. Sometimes surveillance, delivery, postnatal treatment, or comfort-focused care is more appropriate.
Counselling should explain the option of no prenatal intervention, the natural history of the condition, uncertainties in the evidence, procedure-related pregnancy loss or preterm birth, maternal risks, possible need for repeat procedures, follow-up, place of delivery, and expected neonatal care.
A coordinated programme
Fetal therapy is not an isolated technical act. Safe care may involve maternal–fetal medicine, fetal imaging, genetics, paediatric subspecialists, anaesthesia, neonatology, laboratory and blood-bank support, operating-theatre staff, and the referring obstetric team.
In the UAE pathway described here, fetal-therapy procedures are coordinated through Mediclinic Airport Road Hospital in Abu Dhabi. Full diagnostic and referral pathways are available through Mediclinic Al Jowhara Hospital in Al Ain, with Mediclinic referral pathways from Dubai. The dated programme-status panel gives the current classification; treatment depends on diagnosis, multidisciplinary assessment, governance, informed consent, and individual eligibility.
The essential distinctions
Understand the finding. Make room for your questions.
A helpful consultation turns information into a plan you can understand.
- What do we know?
Clarify what is confirmed and what remains uncertain.
- What would change the plan?
Understand the purpose and limits of each proposed test or observation.
- What happens next?
Leave with the next review, contact route, and symptoms that need urgent attention.
Visual decision pathway
From diagnosis to a defensible treatment decision
Fetal therapy begins with diagnostic certainty and ends with coordinated follow-up; the procedure is only one stage.
- ConfirmDefine disease and severity
Verify anatomy, mechanism, gestation, progression and relevant genetic or infection information.
- CompareTest candidacy against evidence
Ask whether prenatal treatment offers meaningful benefit over surveillance, delivery or postnatal care.
- ConsentBalance two-patient risk
Explain maternal, fetal and pregnancy risks, uncertainty, alternatives and repeat-procedure needs.
- CoordinateTreat within a programme
Connect procedure, anaesthesia, laboratory, neonatal, delivery and long-term follow-up systems.